Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC). Annals of oncology : official journal of the European Society for Medical Oncology Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S. N., Patel, S., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L. P., Li, M., Lovly, C. M. 2019; 30 Suppl 2: ii48
View details for DOI 10.1093/annonc/mdz063.010
View details for PubMedID 32131242